UTANG Perubahan Tanggal
AbbVie USD 70.82B 2.04B 2026-06
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 57.3B 19M 2026-06
Ardelyx USD 256.19M 47.93M 2026-06
Arrowhead Research USD 983.69M 5.77M 2026-06
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 7.69B 398.3M 2026-09
Corcept Therapeutics USD 8.99M 430K 2026-09
Curis USD 0 0 2022-06
Gilead Sciences USD 26.25B 4.07B 2026-06
J&J USD 49.04B 5.95B 2026-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 49.01B 2.02B 2026-06
Novavax USD 233.31M 4.23M 2024-09
PTC Therapeutics USD 2.84B 2.15B 2026-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 754.37M 68K 2026-09
Verastem USD 66.79M 26.7M 2024-09
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09